Itama Ranoraya (IRRA) Stock Overview
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
IRRA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
PT Itama Ranoraya Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp432.00 |
| 52 Week High | Rp545.00 |
| 52 Week Low | Rp354.00 |
| Beta | 0.91 |
| 1 Month Change | 1.41% |
| 3 Month Change | 3.35% |
| 1 Year Change | -8.86% |
| 3 Year Change | -63.39% |
| 5 Year Change | -46.99% |
| Change since IPO | -22.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| IRRA | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | 1.4% | -0.2% | 1.3% |
| 1Y | -8.9% | 42.9% | 14.9% |
Return vs Industry: IRRA underperformed the ID Healthcare industry which returned 45.1% over the past year.
Return vs Market: IRRA underperformed the ID Market which returned 13.3% over the past year.
Price Volatility
| IRRA volatility | |
|---|---|
| IRRA Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 4.6% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in ID Market | 15.3% |
| 10% least volatile stocks in ID Market | 2.9% |
Stable Share Price: IRRA has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: IRRA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 144 | Heru Syarif | www.itama.co.id |
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical products; and hospital supplies. It also provides cold chain management, such as cold room, bloodbank, and pharmaceutical refrigerator; critical care; and pharmaceutical supplements, as well as maternal and neonatal care products.
PT Itama Ranoraya Tbk Fundamentals Summary
| IRRA fundamental statistics | |
|---|---|
| Market cap | Rp654.39b |
| Earnings (TTM) | Rp71.01b |
| Revenue (TTM) | Rp1.23t |
Is IRRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IRRA income statement (TTM) | |
|---|---|
| Revenue | Rp1.23t |
| Cost of Revenue | Rp972.85b |
| Gross Profit | Rp260.57b |
| Other Expenses | Rp189.57b |
| Earnings | Rp71.01b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 47.09 |
| Gross Margin | 21.13% |
| Net Profit Margin | 5.76% |
| Debt/Equity Ratio | 147.8% |
How did IRRA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 17:59 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PT Itama Ranoraya Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.